Memorial Şişli Hospital
| Turkey | Thailand | South Korea | |
| Sarcoma surgery | from AUD $13,888 | from AUD $41,663 | from AUD $10,555 |
| Chemotherapy for breast cancer | from AUD $1,667 | from AUD $4,166 | from AUD $26,664 |
| Radiation therapy for colorectal cancer | from AUD $9,721 | from AUD $7,638 | - |
| Radiation Therapy for Sarcomas | from AUD $4,514 | from AUD $9,721 | - |
| Complex treatment of Ewing's sarcoma | from AUD $41,663 | from AUD $48,607 | - |
Professor Zafer Gulbas founded the Bone Marrow Transplantation Centre at Anadolu Medical Centre after training at North America's most prestigious cancer institutes.
Professor Bozkurt is a leading specialist in paediatric oncology who trained at Harvard University's Dana-Farber Cancer Institute – one of the world's most prestigious cancer centres.
Associate Professor Oguzhan Babacan is a specialist in paediatric blood and cancer disorders who has spent 13 years working in bone marrow transplant units.
Associate Professor Hasan Mutlu leads the medical oncology department at Medical Park Antalya, focusing on targeted therapies for complex bone and soft tissue tumours.
Limb-sparing surgeries are the standard approach for Ewing's sarcoma in Turkey when clinically feasible. Turkish oncology centres use bone resections, endoprostheses, and grafts to preserve limbs. Prof. Dr Onder Ofluoglu at Medical Park Göztepe Hospital specialises in these complex reconstructions.
Bookimed Expert Insight: Many centres offer sarcoma surgery. However, Turkish hospitals like Memorial Göztepe and Hisar Intercontinental provide specialised paediatric oncology units. This is vital as Ewing's sarcoma often affects younger patients. These facilities use high-tech diagnostics like 640-slice CT scanners. They also have specialist surgeons who have handled thousands of complex bone resections. This combination improves functional outcomes.
Patient Consensus: Patients note that saving the limb is often possible in Turkey. However, success depends on achieving clear margins during the wide resection. Many emphasise the importance of asking about expected long-term limb function and potential revision surgeries. These discussions should happen before proceeding.
Turkish oncology clinics treat Ewing's sarcoma using multimodal protocols. These mirror international NCCN and ESMO standards. Specialist teams combine intensive chemotherapy, wide-resection surgery, and high-precision radiotherapy. Major Istanbul centres like Anadolu Medical Center and Memorial Bahçelievler use multidisciplinary boards. These boards manage the complex cases.
Bookimed Expert Insight: Turkish centres differentiate themselves through ultra-high-volume bone marrow transplant units. Dr Zafer Gulbas at Anadolu Medical Center reports an 81% success rate for autologous transplants. Our data shows these facilities often serve over 1.6 million patients annually. This gives their multidisciplinary teams vast experience in coordinating chemo with complex reconstructions.
Patient Consensus: Patients in Turkey highlight the importance of clear surgical margins and note that the intensive chemotherapy protocol matches international standards. Many emphasise that a combination of surgery, radiation, and inpatient chemo cycles is the standard path. This leads to recovery.
Turkish hospitals like Anadolu Medical Center and Memorial Bahçelievler provide specialised Ewing's sarcoma care using multidisciplinary tumour boards. These JCI-accredited centres combine limb-sparing surgery with intensive chemotherapy and bone marrow transplants. Patients access radiation technologies including TrueBeam STx and MR-LINAC systems.
Bookimed Expert Insight: While many centres treat adult bone cancer, Ewing's sarcoma requires specific paediatric and adolescent expertise. This is found at hospitals like Biruni University. Prof. Dr Hilmi Apak and Prof. Dr Omer Dogru specialise in both sarcoma immunotherapy and CAR T-cell therapy. Choosing a facility with both paediatric oncology and bone marrow transplant units is vital for managing this aggressive illness.
Patient Consensus: Patients note that Istanbul's university hospitals are excellent for general oncology. However, they emphasise checking if the facility has a dedicated sarcoma board. Experience in Turkey is generally positive due to the available intensive support and diagnostic equipment like PET-CT.
International patients typically start Ewing’s sarcoma diagnostics within 24 to 48 hours. This window begins upon arrival in Turkey. Fast-tracked pathways at Joint Commission International (JCI) accredited centres shorten the timeline. Patients can begin chemotherapy or surgery within 7 to 14 days after multidisciplinary reviews.
Bookimed Expert Insight: Turkish oncology centres like Memorial Göztepe and Anadolu Medical Center use multidisciplinary tumour boards. These boards compress timelines. Data shows that clinics with in-house digital PET/CT and 3 Tesla MRI equipment reduce diagnostic delays significantly. Hisar Hospital is a prime example. This means patients often start their first chemotherapy cycle about one week after biopsy. That rapid timeline is vital for aggressive sarcomas.
Patient Consensus: Patients note that the diagnostic sequence wraps up within a week. This includes MRI and biopsy. They emphasise the importance of choosing hospitals that handle pathology and oncology reviews in-house. This ensures chemotherapy starts immediately after confirmation in Turkey.